Mechanisms for the coupling of cannabinoid receptors to intracellular calcium mobilization in rat insulinoma β-cells

Experimental Cell Research

Volumn 313, Issue 14, 2007, Pages 2993-3004

  De Petrocellis, Luciano ^a   Marini, Pietro ^b   Matias, Isabel ^a   Moriello, Aniello Schiano ^a   Starowicz, Katarzyna ^a   Cristino, Luigia ^a   Nigam, Santosh ^c   Di Marzo, Vincenzo ^a  

^a CNR   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Anandamide, TRPV1; Bombesin; Calcium, insulinoma cells; Cannabinoid receptor

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 1 DEOXY 3 (1,1 DIMETHYLBUTYL) DELTA8 TETRAHYDROCANNABINOL; 1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 2,5 PYRROLIDINEDIONE; 2 AMINOETHOXYDIPHENYLBORANE; 2 MORPHOLINO 8 PHENYLCHROMONE; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; ANANDAMIDE; ARACHIDONOYLCHLOROETHANOLAMIDE; BOMBESIN; CALCIUM; CANNABINOID 2 RECEPTOR; CANNABINOID 2 RECEPTOR AGONIST; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; DANTROLENE; FORSKOLIN; INOSITOL 1,3,4 TRISPHOSPHATE RECEPTOR; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; INSULIN; IONOMYCIN; N ARACHIDONOYLDOPAMINE; PERTUSSIS TOXIN; PHOSPHOINOSITIDE SPECIFIC PHOSPHOLIPASE C INHIBITOR; PHOSPHOLIPASE C INHIBITOR; RIMONABANT; RYANODINE; THAPSIGARGIN; TRANSIENT RECEPTOR POTENTIAL CHANNEL; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANILLOID RECEPTOR; VANILLOID RECEPTOR 1; VANILLOID RECEPTOR ANTAGONIST; WIN 55221 2;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CONTROLLED STUDY; DRUG RECEPTOR BINDING; ENDOPLASMIC RETICULUM; ENZYME INHIBITION; INHIBITION KINETICS; INSULINOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS ISLET CELL; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; RAT; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

RATTUS;

EID: 34547380216     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2007.05.012     Document Type: Article

References (41)

1. Di Marzo V., and Matias I. Endocannabinoid control of food intake and energy balance. Nat. Neurosci. 8 (2005) 585-589
2. Pagotto U., Marsicano G., Cota D., Lutz B., and Pasquali R. The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocr. Rev. 27 (2006) 73-100
3. Monteleone P., Matias I., Martiadis V., De Petrocellis L., Maj M., and Di Marzo V. Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa. Neuropsychopharmacology 30 (2005) 1216-1221
4. Engeli S., Bohnke J., Feldpausch M., Gorzelniak K., Janke J., Batkai S., Pacher P., Harvey-White J., Luft F.C., Sharma A.M., and Jordan J. Activation of the peripheral endocannabinoid system in human obesity. Diabetes 54 (2005) 2838-2843
5. Matias I., Gonthier M.P., Orlando P., Martiadis V., De Petrocellis L., Cervino C., Petrosino S., Hoareau L., Festy F., Pasquali R., Roche R., Maj M., Pagotto U., Monteleone P., and Di Marzo V. Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia. J. Clin. Endocrinol. Metab. 91 (2006) 3171-3180
6. Matias I., and Di Marzo V. Endocannabinoids and the control of energy balance. Trends Endocrinol. Metab. 18 (2007) 27-37
7. B. Liu, C. Hobbs, P. Doherty, P. M. Jones, S. J. Persaud, Diacylglycerol lipase and cannabinoid receptor expression and function in pancreatic beta-cells. 41st EASD Annual Meeting Athens, Greece, (10-15 September 2005) PS 24 Signal transduction in islet cells II no. 443
8. Juan-Pico P., Fuentes E., Javier Bermudez-Silva F., Javier Diaz-Molina F., Ripoll C., Rodriguez de Fonseca F., and Nadal A. Cannabinoid receptors regulate Ca(2+) signals and insulin secretion in pancreatic beta-cell. Cell Calcium 39 (2006) 155-162
9. Fleischmann A., Laderach U., Friess H., Buechler M.W., and Reubi J.C. Bombesin receptors in distinct tissue compartments of human pancreatic diseases. Lab. Invest. 80 (2000) 1807-1817
10. 2+ signaling in clonal beta-cells. Endocrinology 140 (1999) 5516-5523
11. Akiba Y., Kato S., Katsube K., Nakamura M., Takeuchi K., Ishii H., and Hibi T. Transient receptor potential vanilloid subfamily 1 expressed in pancreatic islet beta cells modulates insulin secretion in rats. Biochem. Biophys. Res. Commun. 321 (2004) 219-225
12. 2+ channels. Mol. Pharmacol. 42 (1992) 488-489
13. Hermann H., De Petrocellis L., Bisogno T., Schiano Moriello A., Lutz B., and Di Marzo V. Dual effect of cannabinoid CB1 receptor stimulation on a vanilloid VR1 receptor-mediated response. Cell. Mol. Life Sci. 60 (2003) 607-616
14. De Petrocellis L., Bisogno T., Maccarrone M., Davis J.B., Finazzi-Agro A., and Di Marzo V. The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism. J. Biol. Chem. 276 (2001) 12856-12863
15. Lauckner J.E., Hille B., and Mackie K. The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 19144-19149
16. Felder C.C., Veluz J.S., Williams H.L., Briley E.M., and Matsuda L.A. Cannabinoid agonists stimulate both receptor- and non-receptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones. Mol. Pharmacol. 42 (1992) 838-845
17. Sugiura T., Kondo S., Kishimoto S., Miyashita T., Nakane S., Kodaka T., Suhara Y., Takayama H., and Waku K. Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells. J. Biol. Chem. 275 (2000) 605-612
18. Sugiura T., Kodaka T., Kondo S., Tonegawa T., Nakane S., Kishimoto S., Yamashita A., and Waku K. Inhibition by 2-arachidonoylglycerol, a novel type of possible neuromodulator, of the depolarization-induced increase in intracellular free calcium in neuroblastoma×glioma hybrid NG108-15 cells. Biochem. Biophys. Res. Commun. 233 (1997) 207-210
19. Bisogno T., Melck D., Yu. Bobrov M., Gretskaya N.M., Bezuglov V.V., De Petrocellis L., and Di Marzo V. N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo. Biochem. J. 351 (2000) 224-817
20. Ho B.Y., Uezono Y., Takada S., Takase I., and Izumi F. Coupling of the expressed cannabinoid CB1 and CB2 receptors to phospholipase C and G protein-coupled inwardly rectifying K+ channels. Recept. Channels 6 (1999) 363-374
21. Zoratti C., Kipmen-Korgun D., Osibow K., Malli R., and Graier W.F. Anandamide initiates Ca(2+) signaling via CB2 receptor linked to phospholipase C in calf pulmonary endothelial cells. Br. J. Pharmacol. 140 (2003) 1351-1362
22. 2+]i increases partly sensitive to capacitative store refilling. Eur. J. Pharmacol. 336 (1997) R1-R3
23. Begg M., Baydoun A., Parsons M.E., and Molleman A. Signal transduction of cannabinoid CB1 receptors in a smooth muscle cell line. J. Physiol. 531 (2001) 95-104
24. 2+ levels in human osteosarcoma cells. Chin. J. Physiol. 45 (2002) 95-100
25. Zhuang S.Y., Bridges D., Grigorenko E., McCloud S., Boon A., Hampson R.E., and Deadwyler S.A. Cannabinoids produce neuroprotection by reducing intracellular calcium release from ryanodine-sensitive stores. Neuropharmacology 48 (2005) 1086-1096
26. 2+ signals in cerebellar granule neurons in culture. J. Neurosci. 19 (1999) 8765-8777
27. Sterin-Borda L., Del Zar C.F., and Borda E. Differential CB1 and CB2 cannabinoid receptor-inotropic response of rat isolated atria: endogenous signal transduction pathways. Biochem. Pharmacol. 69 (2005) 1705-1713
28. Murillo-Rodriguez E., Cabeza R., Mendez-Diaz M., Navarro L., and Prospero-Garcia O. Anandamide-induced sleep is blocked by SR141716A, a CB1 receptor antagonist and by U73122, a phospholipase C inhibitor. NeuroReport 12 (2001) 2131-2136
29. Berridge M.J., Lipp P., and Bootman M.D. The versatility and universality of calcium signalling. Nat. Rev., Mol. Cell Biol. 1 (2000) 11-21
30. Moody T.W., and Merali Z. Bombesin-like peptides and associated receptors within the brain: distribution and behavioral implications. Peptides 25 (2004) 511-520
31. Ohki-Hamazaki H., Iwabuchi M., and Maekawa F. Development and function of bombesin-like peptides and their receptors. Int. J. Dev. Biol. 49 (2005) 293-300
32. Bermudez-Siva F.J., Serrano A., Diaz-Molina F.J., Sanchez Vera I., Juan-Pico P., Nadal A., Fuentes E., and Rodriguez de Fonseca F. Activation of cannabinoid CB1 receptors induces glucose intolerance in rats. Eur. J. Pharmacol. 531 (2006) 282-284
33. Vasquez C., and Lewis D.L. The CB1 cannabinoid receptor can sequester G-proteins, making them unavailable to couple to other receptors. J. Neurosci. 19 (1999) 9271-9280
34. Ohki-Hamazaki H., Watase K., Yamamoto K., Ogura H., Yamano M., Yamada K., Maeno H., Imaki J., Kikuyama S., Wada E., and Wada K. Mice lacking bombesin receptor subtype-3 develop metabolic defects and obesity. Nature 390 (1997) 165-169
35. De Petrocellis L., and Di Marzo V. Lipids as regulators of the activity of transient receptor potential type V1 (TRPV1) channels. Life Sci. 77 (2005) 1651-1666
36. Tominaga M., and Tominaga T. Structure and function of TRPV1. Pflugers Arch. 451 (2005) 143-150
37. 2+ by vanilloid receptor I in rat dorsal root ganglion neurons. J. Biol. Chem. 278 (2003) 5462-5472
38. Turner H., Fleig A., Stokes A., Kinet J.P., and Penner R. Discrimination of intracellular calcium store subcompartments using TRPV1 (transient receptor potential channel, vanilloid subfamily member 1) release channel activity. Biochem. J. 371 (2003) 341-350
39. Huang S.M., Bisogno T., Trevisani M., Al-Hayani A., De Petrocellis L., Fezza F., Tognetto M., Krey J.F., Petros T.J., Chu C.J., Miller J.D., Davies S.N., Geppetti P., Walker J.M., and Di Marzo V. An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 8400-8405
40. Morita A., Iwasaki Y., Kobata K., Iida T., Igashi T., Oda K., Suzuki A., Narukawa M., Sasakuma S., Yokogoshi H., Yazawa S., Tominaga M., and Watanabe T. Lipophilicity of capsaicinoids and capsinoids influences the multiple activation process of rat TRPV1. Life Sci. 79 (2006) 2303-2310
41. Nakamichi Y., Wada E., Aoki K., Ohara-Imaizumi M., Kikuta T., Nishiwaki C., Matsushima S., Watanabe T., Wada K., and Nagamatsu S. Functions of pancreatic beta cells and adipocytes in bombesin receptor subtype-3-deficient mice. Biochem. Biophys. Res. Commun. 318 (2004) 698-703